Riskpilot← Back to searchSign inGet full accessBiotech Scandinavia AB
ABBankruptOrg 5594193830Wholesale of perfume and cosmetics · NACE 4645Est. 20230 employees
Revenue 2023
SEK 1,9M
EBITDA margin
5.9%
Equity ratio
13.4%
Financial strength
Net profit 2023
SEK 87K
0 employees
| Revenue | SEK 1,9M | — |
| EBITDA | SEK 111K | — |
| Net profit | SEK 87K | — |
| Total assets | SEK 833K | — |
| Equity | SEK 112K | — |
| Employees | 0 | — |
Legal name
Biotech Scandinavia AB
Org number
5594193830
Legal form
Aktiebolag
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
25 januari 2023
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Företaget köper skönhetsprodukter i grossist-handel och därefter säljer vidare till mindre företagare i mindre mängder.
Address
Email
sales@bioterps.co.uk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 |
|---|---|
| Revenue | 1 887 |
| Staff expenses | — |
| EBITDA | 111 |
| Depreciation & amort. | −0 |
| EBIT | 111 |
| Net financials | −1 |
| Profit before tax | 110 |
| Tax | −23 |
| Net profit | 87 |
| Item | 2023 |
|---|---|
| Total assets | 833 |
| Equity | 112 |
| Long-term debt | 0 |
| Short-term debt | 721 |
| Total debt | 721 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20232023
Equity ratio
13.4%
This company
38.2%
Market median
-65% vs market
20232023
Return on equity
77.7%
This company
18.4%
Market median
+322% vs market
20232023
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
20232023
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
20232023
Debt / equity
6.44×
This company
0.62×
Market median
-939% vs market
20232023
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (4) | ||
| Deputy Board Member | 2023 – 2024 | |
| Board of Directors | 2023 – 2025 | |
| Deputy Board Member | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biotech Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Mats Ture Olofsson | Deputy Board Member | 0 companies |
| Marthin Hamlet Bugge | Board of Directors | 0 companies |
| Kristyna Novakova | Deputy Board Member | 0 companies |
| Mailika Hindrikson Muru | Board of Directors | 0 companies |
| Andreas Hallberg | Deputy Board Member | 0 companies |